Can Leukemia treatment cause heart problems years later
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Can Leukemia Treatment Cause Heart Problems Years Later?
Yes, leukemia treatment can potentially cause heart problems that may develop years after treatment ends. This is an important long-term side effect to understand and monitor.
How Leukemia Treatments Affect the Heart
According to NCCN Guidelines, certain leukemia treatments can damage heart function:
Chemotherapy drugs used in leukemia treatment (particularly anthracyclines, which are common in AML treatment) can weaken the heart muscle over time. This damage may not show up immediately—it can develop months or even years after treatment ends.
Targeted therapies for leukemia can also affect the heart. For example, some targeted drugs can cause a condition called prolonged QTc (a change in your heart's electrical rhythm that can be seen on an EKG). If this becomes too prolonged, it can cause dangerous heart rhythms.
Why This Happens
When chemotherapy drugs circulate through your body, they can damage the cells of your heart muscle. This damage accumulates over time, and the heart's pumping function may gradually weaken—a condition called decreased ejection fraction (meaning less blood is being pumped out with each heartbeat).
Monitoring Your Heart Health
The NCCN Guidelines recommend that patients receive heart tests before starting treatment to establish a baseline. These may include:
- Echocardiogram (ultrasound of the heart) - shows how well your heart pumps
- EKG/ECG (electrocardiogram) - checks your heart's electrical activity
- MUGA scan - creates a movie-like image of your beating heart to measure pumping function
Your care team will likely repeat these tests during and after treatment to monitor for long-term changes.
What You Should Do
During survivorship (the period after treatment ends), it's critical to:
- Keep all follow-up appointments - Your care team should monitor your heart function regularly
- Report symptoms - Tell your doctor about shortness of breath, chest pain, unusual fatigue, or swelling in your legs
- Ask about your risk - Discuss with your oncologist which specific drugs you received and your individual heart risk
- Maintain heart health - Exercise, healthy diet, and managing blood pressure help protect your heart
Questions to Ask Your Care Team
- Which chemotherapy drugs or targeted therapies am I receiving, and do any of them affect heart function?
- What heart tests will I have before, during, and after treatment?
- How often should I have heart monitoring after treatment ends?
- What symptoms should I watch for that might indicate heart problems?
- Are there lifestyle changes I can make to protect my heart during and after treatment?
- Should I see a cardiologist (heart specialist) during or after my leukemia treatment?
Important Context
According to the NCCN Guidelines for Patients, heart monitoring is part of standard survivorship care. Your healthcare team will determine the best monitoring schedule based on:
- The specific drugs you received
- The doses you received
- Your age and overall health
- Any existing heart conditions
The good news is that with regular monitoring and early detection, heart problems can often be managed effectively. This is why maintaining follow-up care is so important—catching any changes early makes a big difference.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Acute Myeloid Leukemia (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Leukemia patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: